Categories
Tags
Authors: Shouman K, Vanichkachorn G, Chesire WP, Suarez MD, Shelly S PMID: 33860871 PMCID: PMC8050227 DOI: 10.1007/s10286-021-00803-8 Abstract Purpose: Post-COVID-19 syndrome is a poorly understood aspect of the current pandemic, with clinical features that overlap with symptoms of autonomic/small fiber dysfunction. An early systematic analysis of autonomic dysfunction following COVID-19 is lacking and may provide [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19
Authors: Wallukat G, Hohberger B, Wenzel K, Furst J, Wallukat A PMID: 33880442 PMCID: PMC8049853 DOI: 10.1016/j.jtauto.2021.100100 Abstract Impairment of health after overcoming the acute phase of COVID-19 is being observed more and more frequently. Here different symptoms of neurological and/or cardiological origin have been reported. With symptoms, which are very similar to the ones [...]
Categories: I-RECOVER Post-Vaccine
Tags: autoantibodies, long COVID
Authors: Porter C, Favara M, Scott D, Craske MG, Stein A PMID: 33858874 PMCID: PMC8053815 DOI: 10.1136/bmjopen-2021-049653 Abstract Objective: To provide evidence on the effect of the COVID-19 pandemic on the mental health of young people who grew up in poverty in low/middle-income countries (LMICs). Design: A phone survey administered between August and October 2020 [...]
Categories: I-RECOVER Post-Vaccine
Tags: Anxiety, COVID-19, Depression
Authors: Karimi A, Naeini F, Azar VA, Hasanzadeh M. PMID: 33940332 DOI: 10.1016/j.phymed.2021.153567 Abstract Background: Sepsis is a life-threatening condition caused by a dysregulated host response to infection. Several studies have indicated that flavonoids exhibit a wide variety of biological actions including free radical scavenging and antioxidant activities. Quercetin, one of the most extensively distributed [...]
Categories: I-PREVENT, I-RECOVER Post-Vaccine
Authors: Schroeder S, Hofer S, Zimmermann A, Pechlaner R, Pendl T, Bergmann M et al. PMID: 33852843 DOI: 10.1016/j.celrep.2021.108985 Abstract Decreased cognitive performance is a hallmark of brain aging, but the underlying mechanisms and potential therapeutic avenues remain poorly understood. Recent studies have revealed health-protective and lifespan-extending effects of dietary spermidine, a natural autophagy-promoting polyamine. [...]
Categories: I-RECOVER Post-Vaccine
Tags: spermidine
Authors: Saha JK, Raihan J PMID: 33867777 PMCID: PMC8039806 DOI: 10.1007/s11224-021-01776-0 Abstract In this study, we have investigated the binding mechanism of two FDA-approved drugs (ivermectin and levosalbutamol) with the spike protein of SARs-CoV-2 using three different computational modeling techniques. Molecular docking results predict that ivermectin shows a large binding affinity for spike protein (− [...]
Categories: I-RECOVER Post-Vaccine
Tags: ivermectin, Levosalbutamol, SARS-CoV-2, Spike Protein
Authors: Theoharides TT, Cholevas C, Polyzoidis K, Poliotis A PMID: 33847020 PMCID: PMC8250989 DOI: 10.1002/biof.1726 Abstract COVID-19 leads to severe respiratory problems, but also to long-COVID syndrome associated primarily with cognitive dysfunction and fatigue. Long-COVID syndrome symptoms, especially brain fog, are similar to those experienced by patients undertaking or following chemotherapy for cancer (chemofog or [...]
Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine
Tags: brain fog, long COVID
Authors: Bello M PMID: 33843474 PMCID: PMC8054936 DOI: 10.1080/07391102.2021.1911857 Abstract Ivermectin (IVM) is an FDA-approved drug that has shown antiviral activity against a wide variety of viruses in recent years. IVM inhibits the formation of the importin-α/β1 heterodimeric complex responsible for the translocation and replication of various viral species proteins. Also, IVM hampers SARS-CoV-2 replication [...]
Categories: I-RECOVER Post-Vaccine
Tags: ivermectin, SARS-CoV-2
Authors: Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J PMID: 33833065 PMCID: PMC8666823 DOI: 10.1136/gutjnl-2021-324090 Abstract We read with great interest the recent article published in Gut in which Yeoh et al demonstrated that gut microbiota composition of recovered patients with COVID-19 remained significantly distinct from uninfected controls. Persisting symptoms, also [...]
Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine
Tags: COVID-19, Gut Microbiota
Authors: Rashid RA, Zgair A, Al-Ani R PMID: 33839489 PMCID: PMC8024226 DOI: 10.1016/j.amjoto.2021.103033 Abstract Objectives: Anosmia is a common debilitating symptom of the novel coronavirus disease 2019 (COVID-19). Currently, there is no satisfactory treatment of anosmia. Therefore, this study was conducted to evaluate the therapeutic effect of nasal betamethasone drops in the recovery of olfaction [...]
Categories: I-RECOVER Post-Vaccine
Tags: Anosmia, Corticosteroids, COVID-19